Talimogene Laherparepvec Enhances the Efficacy of PD-1 Blockade [Melanoma]

Talimogene laherparepvec plus pembrolizumab achieved response in 62% of patients with melanoma.

from Cancer via ola Kala on Inoreader http://ift.tt/2z6fGsO
via IFTTT